Pharmaceutical manufacturers of Theobromine

CSPC Pharmaceutical Group Limited ("CSPC") (Stock code: 1093.HK) is a leading pharmaceutical group in China. The Company has been listed on the Main Board of the Hong Kong Stock Exchange since 1994 and became a constituent stock of the Hang Sang Index in 2018 (the 1st constituent stock in the pharmaceutical sector since launch of the index). CSPC is currently also a constituent stock of the "Hang Seng Composite Index", "Hang Seng Healthcare Index", "Hang Seng SCHK Mainland China Healthcare Index", "Hang Seng Stock Connect Hong Kong Index", "Hang Seng China (Hong Kong-listed) 100 Index" and "Hang Seng China Enterprises Index". CSPC mainly owns two business segments of finished drugs and bulk drugs, with innovative drugs as the core development strategy. CSPC currently has a strong product portfolio in the therapeutic areas of nervous system disease, oncology, anti-infective and cardiovascular disease. Of which "NBP", "Domeisu", "Jinyouli", "Keaili" and "Xuanning" are the most popular innovative drug products in China. Bulk drug products include vitamin C, antibiotics and caffeine series. The manufacturing facilities of CSPC are mainly located in Shijiazhuang City, Hebei Province, China. CSPC has a international R&D team with R&D bases in Shijiazhuang, Shanghai, Beijing and the United States, focusing on the discovery, research and development of small molecule targeted drugs, nano-drugs, monoclonal antibody drugs, bispecific antibody drugs, antibody-drug conjugates and biological drugs in the immune field.

The Bakul Group of enterprises, situated in Mumbai, India, are involved in the production and fabrication of premium Active Pharmaceutical Ingredients (APIs), Intermediates, and Speciality Chemicals. Since establishment in 1975, they have expanded to achieve global eminence in the field of xanthine chemistry. Their expertise lies in the production of APIs like Linagliptin, Pentoxifylline, Theobromine, Doxofylline, Caffeine, Pamabrom, and others.

Shulan City in Jilin Province is where the Shulan Synthetic Pharmaceutical Co., Ltd. is situated, spreading across 120,000 square meters with a registered capital of 15.758 million yuan. It functions as a national designated producer of caffeine, one of only four in the country. The company is in the process of establishing the largest caffeine production facility globally with an annual capacity of 10,000 tons, to be located in the Jilin Economic Development Zone. Upon completion, the entire company will be relocated to the Jilin Economic Development Zone.